Longer-term, Eisai and Biogen are hoping for further evidence to support Leqembi from the phase 3 AHEAD 3-45 trial, which ...

Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous ...

AstraZeneca stocks in London on Tuesday fell by more than 8.0 percent and have ... Another probe related to imports of a ...

AstraZeneca Plc started the week with a market valuation of about £171 billion ($222 billion). By the close on Thursday it ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The global oral controlled release drug delivery technology market is on track for significant expansion, with projections estimating its market value to soar from USD 34.1 billion in 2022 to USD 68.4 ...

AstraZeneca is building a US$1.5 billion manufacturing facility in Tuas South, Singapore, which will create over 800 jobs.

With an array of new medicines and medical devices on display, global medical companies are looking to tap further into the ...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you ...

Pharmaceutical giant AstraZeneca has confirmed that Leon Wang, the head of its China operations, had been detained.

DNA synthesis platform developer joins de novo designer in latest of three partnerships recently launched or advanced.